The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Ocular Genetic Diagnostic Market Research Report 2025
Synopsis
There are around 5,000 genetic disorders and syndromes that affect the mankind. Of this vast number, at least one third of them are related to eyes. With the recent advancements in molecular genetics and various sequencing methods, a wide array of various hereditary eye diseases have been discovered.
The global Ocular Genetic Diagnostic market was valued at US$ 963 million in 2023 and is anticipated to reach US$ 1426.4 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Ocular Genetic Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ocular Genetic Diagnostic.
Report Scope
The Ocular Genetic Diagnostic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ocular Genetic Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ocular Genetic Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Quest Diagnostics
Columbia ophthalmology
Centogene
DBGen
Medgenome
Sankara Nethralaya
Fulgent Genetics
GeneDx
Devyser
Invitae Corporation
Segment by Type
Next-generation Sequencing (NGS)
Multiplex Ligation-Dependent Probe Amplification (MLPA)
Fragment Analysis PCR for Repeat Expansion Analysis
Segment by Application
Hospitals
Diagnostic Laboratories
Academic and Research Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ocular Genetic Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
There are around 5,000 genetic disorders and syndromes that affect the mankind. Of this vast number, at least one third of them are related to eyes. With the recent advancements in molecular genetics and various sequencing methods, a wide array of various hereditary eye diseases have been discovered.
The global Ocular Genetic Diagnostic market was valued at US$ 963 million in 2023 and is anticipated to reach US$ 1426.4 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Ocular Genetic Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ocular Genetic Diagnostic.
Report Scope
The Ocular Genetic Diagnostic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ocular Genetic Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ocular Genetic Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Quest Diagnostics
Columbia ophthalmology
Centogene
DBGen
Medgenome
Sankara Nethralaya
Fulgent Genetics
GeneDx
Devyser
Invitae Corporation
Segment by Type
Next-generation Sequencing (NGS)
Multiplex Ligation-Dependent Probe Amplification (MLPA)
Fragment Analysis PCR for Repeat Expansion Analysis
Segment by Application
Hospitals
Diagnostic Laboratories
Academic and Research Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ocular Genetic Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ocular Genetic Diagnostic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Next-generation Sequencing (NGS)
1.2.3 Multiplex Ligation-Dependent Probe Amplification (MLPA)
1.2.4 Fragment Analysis PCR for Repeat Expansion Analysis
1.3 Market by Application
1.3.1 Global Ocular Genetic Diagnostic Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Academic and Research Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Ocular Genetic Diagnostic Market Perspective (2019-2030)
2.2 Ocular Genetic Diagnostic Growth Trends by Region
2.2.1 Global Ocular Genetic Diagnostic Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Ocular Genetic Diagnostic Historic Market Size by Region (2019-2024)
2.2.3 Ocular Genetic Diagnostic Forecasted Market Size by Region (2025-2030)
2.3 Ocular Genetic Diagnostic Market Dynamics
2.3.1 Ocular Genetic Diagnostic Industry Trends
2.3.2 Ocular Genetic Diagnostic Market Drivers
2.3.3 Ocular Genetic Diagnostic Market Challenges
2.3.4 Ocular Genetic Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ocular Genetic Diagnostic Players by Revenue
3.1.1 Global Top Ocular Genetic Diagnostic Players by Revenue (2019-2024)
3.1.2 Global Ocular Genetic Diagnostic Revenue Market Share by Players (2019-2024)
3.2 Global Ocular Genetic Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Ocular Genetic Diagnostic Revenue
3.4 Global Ocular Genetic Diagnostic Market Concentration Ratio
3.4.1 Global Ocular Genetic Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ocular Genetic Diagnostic Revenue in 2023
3.5 Ocular Genetic Diagnostic Key Players Head office and Area Served
3.6 Key Players Ocular Genetic Diagnostic Product Solution and Service
3.7 Date of Enter into Ocular Genetic Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Ocular Genetic Diagnostic Breakdown Data by Type
4.1 Global Ocular Genetic Diagnostic Historic Market Size by Type (2019-2024)
4.2 Global Ocular Genetic Diagnostic Forecasted Market Size by Type (2025-2030)
5 Ocular Genetic Diagnostic Breakdown Data by Application
5.1 Global Ocular Genetic Diagnostic Historic Market Size by Application (2019-2024)
5.2 Global Ocular Genetic Diagnostic Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Ocular Genetic Diagnostic Market Size (2019-2030)
6.2 North America Ocular Genetic Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Ocular Genetic Diagnostic Market Size by Country (2019-2024)
6.4 North America Ocular Genetic Diagnostic Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Ocular Genetic Diagnostic Market Size (2019-2030)
7.2 Europe Ocular Genetic Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Ocular Genetic Diagnostic Market Size by Country (2019-2024)
7.4 Europe Ocular Genetic Diagnostic Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Ocular Genetic Diagnostic Market Size (2019-2030)
8.2 Asia-Pacific Ocular Genetic Diagnostic Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Ocular Genetic Diagnostic Market Size by Region (2019-2024)
8.4 Asia-Pacific Ocular Genetic Diagnostic Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Ocular Genetic Diagnostic Market Size (2019-2030)
9.2 Latin America Ocular Genetic Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Ocular Genetic Diagnostic Market Size by Country (2019-2024)
9.4 Latin America Ocular Genetic Diagnostic Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ocular Genetic Diagnostic Market Size (2019-2030)
10.2 Middle East & Africa Ocular Genetic Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Ocular Genetic Diagnostic Market Size by Country (2019-2024)
10.4 Middle East & Africa Ocular Genetic Diagnostic Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Quest Diagnostics
11.1.1 Quest Diagnostics Company Detail
11.1.2 Quest Diagnostics Business Overview
11.1.3 Quest Diagnostics Ocular Genetic Diagnostic Introduction
11.1.4 Quest Diagnostics Revenue in Ocular Genetic Diagnostic Business (2019-2024)
11.1.5 Quest Diagnostics Recent Development
11.2 Columbia ophthalmology
11.2.1 Columbia ophthalmology Company Detail
11.2.2 Columbia ophthalmology Business Overview
11.2.3 Columbia ophthalmology Ocular Genetic Diagnostic Introduction
11.2.4 Columbia ophthalmology Revenue in Ocular Genetic Diagnostic Business (2019-2024)
11.2.5 Columbia ophthalmology Recent Development
11.3 Centogene
11.3.1 Centogene Company Detail
11.3.2 Centogene Business Overview
11.3.3 Centogene Ocular Genetic Diagnostic Introduction
11.3.4 Centogene Revenue in Ocular Genetic Diagnostic Business (2019-2024)
11.3.5 Centogene Recent Development
11.4 DBGen
11.4.1 DBGen Company Detail
11.4.2 DBGen Business Overview
11.4.3 DBGen Ocular Genetic Diagnostic Introduction
11.4.4 DBGen Revenue in Ocular Genetic Diagnostic Business (2019-2024)
11.4.5 DBGen Recent Development
11.5 Medgenome
11.5.1 Medgenome Company Detail
11.5.2 Medgenome Business Overview
11.5.3 Medgenome Ocular Genetic Diagnostic Introduction
11.5.4 Medgenome Revenue in Ocular Genetic Diagnostic Business (2019-2024)
11.5.5 Medgenome Recent Development
11.6 Sankara Nethralaya
11.6.1 Sankara Nethralaya Company Detail
11.6.2 Sankara Nethralaya Business Overview
11.6.3 Sankara Nethralaya Ocular Genetic Diagnostic Introduction
11.6.4 Sankara Nethralaya Revenue in Ocular Genetic Diagnostic Business (2019-2024)
11.6.5 Sankara Nethralaya Recent Development
11.7 Fulgent Genetics
11.7.1 Fulgent Genetics Company Detail
11.7.2 Fulgent Genetics Business Overview
11.7.3 Fulgent Genetics Ocular Genetic Diagnostic Introduction
11.7.4 Fulgent Genetics Revenue in Ocular Genetic Diagnostic Business (2019-2024)
11.7.5 Fulgent Genetics Recent Development
11.8 GeneDx
11.8.1 GeneDx Company Detail
11.8.2 GeneDx Business Overview
11.8.3 GeneDx Ocular Genetic Diagnostic Introduction
11.8.4 GeneDx Revenue in Ocular Genetic Diagnostic Business (2019-2024)
11.8.5 GeneDx Recent Development
11.9 Devyser
11.9.1 Devyser Company Detail
11.9.2 Devyser Business Overview
11.9.3 Devyser Ocular Genetic Diagnostic Introduction
11.9.4 Devyser Revenue in Ocular Genetic Diagnostic Business (2019-2024)
11.9.5 Devyser Recent Development
11.10 Invitae Corporation
11.10.1 Invitae Corporation Company Detail
11.10.2 Invitae Corporation Business Overview
11.10.3 Invitae Corporation Ocular Genetic Diagnostic Introduction
11.10.4 Invitae Corporation Revenue in Ocular Genetic Diagnostic Business (2019-2024)
11.10.5 Invitae Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Ocular Genetic Diagnostic Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Next-generation Sequencing (NGS)
Table 3. Key Players of Multiplex Ligation-Dependent Probe Amplification (MLPA)
Table 4. Key Players of Fragment Analysis PCR for Repeat Expansion Analysis
Table 5. Global Ocular Genetic Diagnostic Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Ocular Genetic Diagnostic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Ocular Genetic Diagnostic Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Ocular Genetic Diagnostic Market Share by Region (2019-2024)
Table 9. Global Ocular Genetic Diagnostic Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Ocular Genetic Diagnostic Market Share by Region (2025-2030)
Table 11. Ocular Genetic Diagnostic Market Trends
Table 12. Ocular Genetic Diagnostic Market Drivers
Table 13. Ocular Genetic Diagnostic Market Challenges
Table 14. Ocular Genetic Diagnostic Market Restraints
Table 15. Global Ocular Genetic Diagnostic Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Ocular Genetic Diagnostic Market Share by Players (2019-2024)
Table 17. Global Top Ocular Genetic Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ocular Genetic Diagnostic as of 2023)
Table 18. Ranking of Global Top Ocular Genetic Diagnostic Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Ocular Genetic Diagnostic Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Ocular Genetic Diagnostic Product Solution and Service
Table 22. Date of Enter into Ocular Genetic Diagnostic Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Ocular Genetic Diagnostic Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Ocular Genetic Diagnostic Revenue Market Share by Type (2019-2024)
Table 26. Global Ocular Genetic Diagnostic Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Ocular Genetic Diagnostic Revenue Market Share by Type (2025-2030)
Table 28. Global Ocular Genetic Diagnostic Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Ocular Genetic Diagnostic Revenue Market Share by Application (2019-2024)
Table 30. Global Ocular Genetic Diagnostic Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Ocular Genetic Diagnostic Revenue Market Share by Application (2025-2030)
Table 32. North America Ocular Genetic Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Ocular Genetic Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Ocular Genetic Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Ocular Genetic Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Ocular Genetic Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Ocular Genetic Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Ocular Genetic Diagnostic Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Ocular Genetic Diagnostic Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Ocular Genetic Diagnostic Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Ocular Genetic Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Ocular Genetic Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Ocular Genetic Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Ocular Genetic Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Ocular Genetic Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Ocular Genetic Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 47. Quest Diagnostics Company Detail
Table 48. Quest Diagnostics Business Overview
Table 49. Quest Diagnostics Ocular Genetic Diagnostic Product
Table 50. Quest Diagnostics Revenue in Ocular Genetic Diagnostic Business (2019-2024) & (US$ Million)
Table 51. Quest Diagnostics Recent Development
Table 52. Columbia ophthalmology Company Detail
Table 53. Columbia ophthalmology Business Overview
Table 54. Columbia ophthalmology Ocular Genetic Diagnostic Product
Table 55. Columbia ophthalmology Revenue in Ocular Genetic Diagnostic Business (2019-2024) & (US$ Million)
Table 56. Columbia ophthalmology Recent Development
Table 57. Centogene Company Detail
Table 58. Centogene Business Overview
Table 59. Centogene Ocular Genetic Diagnostic Product
Table 60. Centogene Revenue in Ocular Genetic Diagnostic Business (2019-2024) & (US$ Million)
Table 61. Centogene Recent Development
Table 62. DBGen Company Detail
Table 63. DBGen Business Overview
Table 64. DBGen Ocular Genetic Diagnostic Product
Table 65. DBGen Revenue in Ocular Genetic Diagnostic Business (2019-2024) & (US$ Million)
Table 66. DBGen Recent Development
Table 67. Medgenome Company Detail
Table 68. Medgenome Business Overview
Table 69. Medgenome Ocular Genetic Diagnostic Product
Table 70. Medgenome Revenue in Ocular Genetic Diagnostic Business (2019-2024) & (US$ Million)
Table 71. Medgenome Recent Development
Table 72. Sankara Nethralaya Company Detail
Table 73. Sankara Nethralaya Business Overview
Table 74. Sankara Nethralaya Ocular Genetic Diagnostic Product
Table 75. Sankara Nethralaya Revenue in Ocular Genetic Diagnostic Business (2019-2024) & (US$ Million)
Table 76. Sankara Nethralaya Recent Development
Table 77. Fulgent Genetics Company Detail
Table 78. Fulgent Genetics Business Overview
Table 79. Fulgent Genetics Ocular Genetic Diagnostic Product
Table 80. Fulgent Genetics Revenue in Ocular Genetic Diagnostic Business (2019-2024) & (US$ Million)
Table 81. Fulgent Genetics Recent Development
Table 82. GeneDx Company Detail
Table 83. GeneDx Business Overview
Table 84. GeneDx Ocular Genetic Diagnostic Product
Table 85. GeneDx Revenue in Ocular Genetic Diagnostic Business (2019-2024) & (US$ Million)
Table 86. GeneDx Recent Development
Table 87. Devyser Company Detail
Table 88. Devyser Business Overview
Table 89. Devyser Ocular Genetic Diagnostic Product
Table 90. Devyser Revenue in Ocular Genetic Diagnostic Business (2019-2024) & (US$ Million)
Table 91. Devyser Recent Development
Table 92. Invitae Corporation Company Detail
Table 93. Invitae Corporation Business Overview
Table 94. Invitae Corporation Ocular Genetic Diagnostic Product
Table 95. Invitae Corporation Revenue in Ocular Genetic Diagnostic Business (2019-2024) & (US$ Million)
Table 96. Invitae Corporation Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ocular Genetic Diagnostic Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Ocular Genetic Diagnostic Market Share by Type: 2023 VS 2030
Figure 3. Next-generation Sequencing (NGS) Features
Figure 4. Multiplex Ligation-Dependent Probe Amplification (MLPA) Features
Figure 5. Fragment Analysis PCR for Repeat Expansion Analysis Features
Figure 6. Global Ocular Genetic Diagnostic Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Ocular Genetic Diagnostic Market Share by Application: 2023 VS 2030
Figure 8. Hospitals Case Studies
Figure 9. Diagnostic Laboratories Case Studies
Figure 10. Academic and Research Centers Case Studies
Figure 11. Others Case Studies
Figure 12. Ocular Genetic Diagnostic Report Years Considered
Figure 13. Global Ocular Genetic Diagnostic Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Ocular Genetic Diagnostic Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Ocular Genetic Diagnostic Market Share by Region: 2023 VS 2030
Figure 16. Global Ocular Genetic Diagnostic Market Share by Players in 2023
Figure 17. Global Top Ocular Genetic Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ocular Genetic Diagnostic as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Ocular Genetic Diagnostic Revenue in 2023
Figure 19. North America Ocular Genetic Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Ocular Genetic Diagnostic Market Share by Country (2019-2030)
Figure 21. United States Ocular Genetic Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Ocular Genetic Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Ocular Genetic Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Ocular Genetic Diagnostic Market Share by Country (2019-2030)
Figure 25. Germany Ocular Genetic Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Ocular Genetic Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Ocular Genetic Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Ocular Genetic Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Ocular Genetic Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Ocular Genetic Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Ocular Genetic Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Ocular Genetic Diagnostic Market Share by Region (2019-2030)
Figure 33. China Ocular Genetic Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Ocular Genetic Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Ocular Genetic Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Ocular Genetic Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Ocular Genetic Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Ocular Genetic Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Ocular Genetic Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Ocular Genetic Diagnostic Market Share by Country (2019-2030)
Figure 41. Mexico Ocular Genetic Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Ocular Genetic Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Ocular Genetic Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Ocular Genetic Diagnostic Market Share by Country (2019-2030)
Figure 45. Turkey Ocular Genetic Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Ocular Genetic Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Quest Diagnostics Revenue Growth Rate in Ocular Genetic Diagnostic Business (2019-2024)
Figure 48. Columbia ophthalmology Revenue Growth Rate in Ocular Genetic Diagnostic Business (2019-2024)
Figure 49. Centogene Revenue Growth Rate in Ocular Genetic Diagnostic Business (2019-2024)
Figure 50. DBGen Revenue Growth Rate in Ocular Genetic Diagnostic Business (2019-2024)
Figure 51. Medgenome Revenue Growth Rate in Ocular Genetic Diagnostic Business (2019-2024)
Figure 52. Sankara Nethralaya Revenue Growth Rate in Ocular Genetic Diagnostic Business (2019-2024)
Figure 53. Fulgent Genetics Revenue Growth Rate in Ocular Genetic Diagnostic Business (2019-2024)
Figure 54. GeneDx Revenue Growth Rate in Ocular Genetic Diagnostic Business (2019-2024)
Figure 55. Devyser Revenue Growth Rate in Ocular Genetic Diagnostic Business (2019-2024)
Figure 56. Invitae Corporation Revenue Growth Rate in Ocular Genetic Diagnostic Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
